Among those, receptor tyrosine kinases (EGFR, FGFR, and VEGFR) signaling through Ras-MAPK or Ras-PI3K-Akt axes are the most frequently hyperactive pathways implicated in bladder cancer progression [25–27]. This evidence concerns the gene KDR and urinary bladder carcinoma.